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Cell Shape, Cytoskeletal Tension, and RhoA
Regulate Stem Cell Lineage Commitment
several studies have noted that changes in cell shape
themselves can alter the differentiation of precommitted
mesenchymal lineages. Spiegelman and Ginty (1983)
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found that when the adipogenic cell line 3T3-F442A was1The Cellular and Molecular Medicine Program
allowed to attach and spread on surfaces coated with2 Department of Biomedical Engineering
fibronectin, differentiation as evidenced by lipogenic3 Department of Oncology
gene expression was inhibited. These inhibitory effectsThe Johns Hopkins University School of Medicine
of cell spreading on adipogenic differentiation were re-Baltimore, Maryland 21205
versed when cells were kept round, or upon disruption
of the actin cytoskeleton (Spiegelman and Ginty, 1983;
Rodriguez Fernandez and Ben-Ze’ev, 1989). In contrast,Summary
cell spreading has been shown to increase osteoblast
differentiation in preosteoblastic progenitors as mea-Commitment of stem cells to different lineages is regu-
sured by increased osteopontin and osteocalcin expres-lated by many cues in the local tissue microenviron-
sion (Carvalho et al., 1998; Thomas et al., 2002). In thisment. Here we demonstrate that cell shape regulates
case, differentiation requires an intact cytoskeleton (Pa-commitment of human mesenchymal stem cells (hMSCs)
valko et al., 1998; Toma et al., 1997). While changesto adipocyte or osteoblast fate. hMSCs allowed to
in cell shape and cytoskeletal integrity appear to beadhere, flatten, and spread underwent osteogenesis,
important in differentiation of certain lineages, little iswhile unspread, round cells became adipocytes. Cell
known about whether cell shape affects earlier develop-shape regulated the switch in lineage commitment
mental stages, such as the commitment of a multipoten-by modulating endogenous RhoA activity. Expressing
tial stem cell.dominant-negative RhoA committed hMSCs to be-
Recently, human mesenchymal stem cells (hMSCs)come adipocytes, while constitutively active RhoA
have been isolated from adult bone marrow that arecaused osteogenesis. However, the RhoA-mediated
capable of differentiation to multiple lineages importantadipogenesis or osteogenesis was conditional on a
to connective tissue (Pittenger et al., 1999). These adher-round or spread shape, respectively, while constitutive
ent cells differentiate into adipocytes, osteoblasts, andactivation of the RhoA effector, ROCK, induced os-
chondrocytes when exposed to various growth factorteogenesis independent of cell shape. This RhoA-
combinations (Pittenger et al., 1999, 2002). Importantly,ROCK commitment signal required actin-myosin-
it was noted that differentiation into these lineages onlygenerated tension. These studies demonstrate that
occurred if cells were plated at appropriate densities.mechanical cues experienced in developmental and
While much is known about how each of the growthadult contexts, embodied by cell shape, cytoskeletal
factors regulates lineage specification and differentia-tension, and RhoA signaling, are integral to the com-
tion, little is known about the significance of the cellmitment of stem cell fate.
density requirement in these protocols. We hypothe-
sized that these differences in cell density confer differ-Introduction
ences in cell shape and that cell shape acts as a cue in
the commitment process.Connective tissue cells differ greatly in phenotype. Al-
While cell shape has been shown to regulate biologi-though they descend from a common mesenchymal
cal processes such as proliferation (Chen et al., 1997)
stem cell (MSC) precursor, differentiated adipocytes are
and differentiation (Watt et al., 1988; Roskelley et al.,
round and fat-laden (Green and Kehinde, 1974; Gregoire
1994), the molecular basis of these cell shape-mediated
et al., 1998), while osteoblasts vary from elongated to effects has remained ill defined. Recent studies suggest
cuboidal, depending on their matrix deposition activity that cell shape may affect activity in Rho family GTPases
(Grigoriadis et al., 1988; Sikavitsas et al., 2001). The (Ren et al., 1999). Numerous studies show that Rho
shapes of these cells serve their specialized functions, GTPases are critical to proliferation (Hill et al., 1995;
while simultaneously driving their multicellular organiza- Welsh et al., 2001) and differentiation (Takano et al.,
tion (Thompson, 1992). A round, spherical shape allows 1998; Sordella et al., 2003). Recently, a cytoskeletal-
for maximal lipid storage in adipose tissue, while cell independent role for Rho was proposed to determine
spreading facilitates osteoblast matrix deposition dur- the differentiation of mouse embryonic fibroblasts into
ing bone remodeling (Parfitt, 1984). These different cell adipocytes and myoblasts (Sordella et al., 2003), sug-
morphologies are thought to arise from changes in the gesting a role for Rho GTPase signaling in early cellular
expression of integrins, cadherins, and cytoskeletal pro- developmental processes.
teins (Gumbiner, 1996) during stem cell commitment, Here, we set out to examine whether changes in cell
the process by which a cell chooses its fate, and differ- shape can regulate commitment of mesenchymal cells
entiation, the subsequent development of lineage-spe- to different lineages, and if so, how. We chose to use
cific characteristics (Hu et al., 1995). hMSCs to examine the commitment process, as the
While differentiation may cause changes in cell shape, ability of these cells to become adipocytes and osteo-
blasts from multipotent mesenchymal precursor cells
has been well documented (Friedenstein, 1976; Caplan,*Correspondence: cchen@bme.jhu.edu
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1991; Pittenger et al., 1999). Using a micropatterning increasing concentrations of a DNA polymerase inhibitor
technique to control cell shape and degree of cell (aphidicolin) or an alkylating agent (mitomycin C) to
spreading with single-cell precision, thousands of cells hMSCs to identify working concentrations of inhibitors.
at a time, we have identified cell shape as a key regulator Prolonged exposure to aphidicolin (2 g/ml) or mitomy-
in hMSC commitment to the osteoblast or adipocyte cin C (10 g/ml) demonstrated growth arrest without
lineages. This shape-dependent control of lineage com- obvious toxicity (Figure 2A). Aphidicolin or mitomycin
mitment is mediated by RhoA activity, specifically via C-treated hMSCs were plated at high or low density in
its effects on ROCK-mediated cytoskeletal tension. In adipogenic or osteogenic media and stained for lipids
fact, controlling RhoA activity completely supplanted or AP after 1 week. Irrespective of cell proliferation,
the need for soluble differentiation factors. This study hMSCs became adipocytes only at high plating density,
demonstrates that cell shape and cytoskeletal mechan- while osteoblastic commitment was favored at low den-
ics drive stem cell commitment, and it points to a molec- sity (Figures 2B and 2C). Thus, the density effects on
ular pathway by which this occurs. both adipocyte and osteoblast differentiation occur in-
dependently of cell proliferation.
Results To more directly investigate the role of cell density in
commitment, we examined adipogenesis and osteo-
hMSC Commitment Depends on Cell Density genesis simultaneously in cultures exposed to a mixed
Previous studies suggested that initial plating densities media containing both adipogenic and osteogenic fac-
affect optimal differentiation of hMSCs (Pittenger et al.,
tors, as well as the proliferation inhibitors aphidicolin or
1999). To confirm this effect, we examined hMSC differ-
mitomycin C. Cells were plated at high or low densities
entiation to the osteoblastic and adipogenic lineages
for 4 weeks and costained for AP and lipids (Figure 2D).when plated at different densities in osteogenic or adi-
At high densities, cells favored adipogenesis, while cellspogenic culture media. Early passage hMSCs were
switched to an osteogenic fate at low densities (Figuresplated at four densities (1000 to 25,000 cells/cm2) and
2E and 2F).cultured in osteogenic or adipogenic differentiation me-
While these findings suggested that plating densitydia for up to 4 weeks. Cells were collected every week
might directly affect hMSC lineage commitment, a pos-and stained for alkaline phosphatase or lipids, markers
sible mechanism for the enrichment of specific lineagesof osteogenesis and adipogenesis, respectively. At the
is through a density-dependent, differential survival ad-lowest plating density, cells attached with little interac-
vantage for adipocytes versus osteoblasts. To exploretion between neighboring cells. At the highest density,
this possibility, we investigated whether hMSCs thatcells were effectively confluent upon plating. In adipo-
had already differentiated into adipocytes or osteoblastsgenic media, cells seeded at low density did not form
exhibited preferential survival in low- or high-densitythe stereotypic fat globules indicative of adipogenesis,
culture. hMSCs were differentiated into adipocytes atbut did at high density (Figures 1A and 1C). Conversely,
high plating density or into osteoblasts at low platingin osteogenic media, more cells expressed alkaline
density, and replated at low or high density, respectively.phosphatase at low density than at high density (Figures
After 1 week, adipocytes and osteoblasts showed1B and 1D). As cells generally stained intensely for the
markers or not at all, the degree of adipogenesis or equally high viability, irrespective of replating density
osteogenesis was quantified by counting the percent- (Figure 2G). These results suggest that initial plating
age of cells labeled (Figures 1E and 1F; Supplemen- density does not affect the lineage outcomes by select-
tal Figure S1 [http://www.developmentalcell.com/cgi/ ing adipogenic subpopulations at high density, or os-
content/full/6/4/483/DC1]). To confirm these findings, teogenic subpopulations at low density. Instead, cell
we performed semiquantitative RT-PCR on 1-week cul- density appeared to directly alter whether hMSCs differ-
tures to detect molecular markers of the adipocyte and entiated into one lineage versus another.
osteoblast lineages. Adipocyte markers lipoprotein li- hMSC adipogenesis and osteogenesis are both
pase (Lpl) and peroxisome proliferator activator recep- thought to involve distinct commitment and differentia-
tor  2 (PPAR2), and osteoblast markers alkaline phos- tion steps (Smas and Sul, 1997; Gregoire et al., 1998;
phatase (AP) and core binding factor  1 (Cbfa1), Franceschi, 1999). To investigate whether cell density
confirmed the density-dependent effects on hMSC dif- can act specifically on the lineage commitment process,
ferentiation (Figures 1I and 1J).
prior to differentiation, hMSCs were plated at high or
One uncontrolled and confounding aspect of these
low density for 4 days without soluble differentiationextended experiments was cell proliferation. Because
factors. Cells were then suspended and replated at highcells continued to divide during the course of the study,
or low density for 1 week in mixed differentiation mediacell density increased with time, and increased at differ-
conditions. As in the earlier experiments, high replatingent rates depending on experimental conditions (Figures
density induced adipogenesis while suppressing os-1G and 1H). Furthermore, proliferation rates increased
teogenesis. Interestingly, preculturing hMSCs at lowat low plating densities and in osteogenic differentiation
density significantly inhibited adipogenic commitmentmedia, and arrested at high densities and in adipogenic
(Figure 2H), while preculturing at high density preventeddifferentiation media. These observations raised the
osteogenesis (Figure 2I). These findings suggest thatpossibility that proliferation or the cell cycle itself may be
hMSC lineage commitment can be initiated indepen-linked to lineage commitment, as has been suggested by
dently from the downstream steps of differentiation, andother studies (Shao and Lazar, 1997; Fajas, 2003).
that initial plating density alone can drive this com-To eliminate these ambiguities, we examined differen-
tiation in proliferation-arrested cells. We administered mitment.
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Figure 1. hMSC Adipogenesis versus Os-
teogenesis Depends on Cell Density
(A–D) Brightfield images of hMSCs plated at
1000 cells/cm2 (A and B) or 25,000 cells/cm2
(C and D), cultured for 4 weeks in adipogenic
(A and C) or 3 weeks in osteogenic (B and
D) differentiation media, and stained for the
presence of lipids (A and C) or alkaline phos-
phatase (B and D). Scale bar  200 m.
(E and F) Plot of hMSC percentage differenti-
ation over time when cultured at 1000, 3000,
21,000, or 25,000 cells/cm2 in the presence
of adipogenic differentiation media (E) or os-
teogenic differentiation media (F).
(G and H) Plot of hMSC relative density over
time when plated at the different seeding den-
sities in the presence of adipogenic (G) or
osteogenic (H) differentiation media.
(I and J) RT-PCR for adipogenic (I) or osteoge-
nic (J) differentiation markers of hMSCs
plated at the indicated densities and cultured
in adipogenic (I) or osteogenic (J) differentia-
tion media. Samples were collected after 1 week
in culture. Control, cells plated at 3000 cells/
cm2 exposed to nondifferentiating growth
media; Lpl, lipoprotein lipase; PPAR2, per-
oxisome proliferator activated receptor  2;
Alkphos, alkaline phosphatase; Cbfa1, core
binding factor  1; 2mg, -2-microglobulin.
Cell Shape Drives hMSC Commitment specifically the role of cell shape on stem cell commit-
ment. We microcontact printed fibronectin onto polydi-Many cues in the local environment change when cells
are grown at different densities. With increasing density, methylsiloxane (PDMS) substrates to generate “islands”
of fibronectin surrounded by regions blocked with thecell adhesion and spreading against the substrate de-
crease, while cell-cell contact and paracrine signaling nonadhesive, Pluronic F108. hMSCs plated onto these
islands attached as single cells per island, and spreadincrease. Conventional techniques are unable to sepa-
rate the effects of these different cues (Nelson and Chen, to different degrees depending on the size of the islands
(1024 or 10,000 m2; Figure 3A). The cells were cultured2002). Here, using micropatterned substrates to control
the degree of cell spreading against the substrate in on these islands in mixed media for 1 week, then fixed
and stained for both AP and lipids.the absence of cell-cell communication, we explored
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Figure 2. Density-Dependent Adipogenesis versus Osteogenesis Results from Differential Lineage Commitment, Not Differential Proliferation
or Survival
(A) Plot of hMSC density over time with or without aphidicolin (2 g/ml) or mitomycin C (10 g/ml) treatment.
(B and C) Percentage of hMSC adipogenesis (B) or osteogenesis (C) at 3000 or 25,000 cells/cm2 plating density after 1 week with or without
aphidicolin or mitomycin C treatment.
(D) Brightfield image of hMSCs exposed to mixed media (combined osteogenic and adipogenic media). Alkaline phosphatase stains blue;
lipids stain red. Scale bar  50 m.
(E and F) Percentage of hMSC adipogenic (E) or osteogenic (F) differentiation 4 weeks after plating at 1000, 3000, 21,000, or 25,000 cells/cm2
in mixed media conditions with or without aphidicolin or mitomycin C treatment.
(G) Percentage of adipocyte or osteoblast viability when replated at 3000 or 25,000 cells/cm2, respectively.
(H and I) Percentage of adipogenesis (H) or osteogenesis (I) when hMSCs initially plated at high (25,000 cells/cm2) or low density (3000 cells/
cm2) in nondifferentiating growth media were replated at low or high density and cultured for 1 week in mixed media.
hMSC adipogenesis occurred only on small islands, lineage enrichment on micropatterns resulted from dif-
ferential apoptotic selection of adipocytes versus osteo-osteogenesis occurred only on large islands, and a mix-
ture of both lineages was found on intermediate-sized blasts, cells were plated onto small or large islands,
counted, and cultured in mixed media with aphidicolinislands (Figure 3B). The percentage of lipid- or AP-
stained cells was determined for islands containing sin- for 1 week. Cells were then recounted and assayed for
viability. Micropatterning did not cause significant de-gle cells, demonstrating a marked effect of cell shape
on commitment. Similar results were obtained when in- creases in total cell number or viability (Figure 3D), indi-
cating that the highly enriched lineage-specific cell pop-hibiting proliferation by patterning the cells in the pres-
ence of aphidicolin (Figure 3C). To address whether the ulations are not selected based on preferential survival
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on the micropatterns. In all, these results suggest that
changes in cell shape alone are sufficient to mediate
the switch in hMSC commitment between adipogenic
and osteogenic fates. Furthermore, because the effects
of cell shape on commitment persist in the absence of
proliferation or apoptosis, the effects of cell shape on
proliferation or survival are distinct from those on cell
fate determination.
hMSC Commitment Varies with Changes
in Cytoskeletal Tension
Changes in cell shape may be transduced into a regula-
tory signal by several structures in the cell, including
the actin cytoskeleton itself (Huang et al., 1998). In fact,
sparsely plated and well-spread hMSCs exhibited more
prominent stress fibers as compared to densely plated
and unspread cells. To examine whether the actin cy-
toskeleton was involved in the shape-mediated commit-
ment process, hMSCs were first cultured with the actin-
disrupting agent cytochalasin D in mixed differentiation
media conditions at low plating density. Lipid and AP
staining revealed that disrupting actin increased adipo-
genesis and decreased osteogenesis as compared to
untreated controls (Figures 4A and 4B). While these data
suggested that the actin cytoskeleton might be impor-
tant in the commitment process, we observed that the
drug treatment also caused cells to become rounded
(Figure 4A). Thus it remained unclear whether cytocha-
lasin D affected commitment primarily by changing cell
shape or disrupting the actin cytoskeleton.
To address this ambiguity, we impaired the actin cy-
toskeleton by specifically inhibiting myosin-generated
cytoskeletal tension. hMSCs were cultured in mixed me-
dia in the presence of Y-27632 (10 M), an inhibitor of
Rho kinase (ROCK), the Rho effector involved in myosin
activation (Kimura et al., 1996). In the presence of
Y-27632, cells remained spread and morphologically
similar to untreated controls (Figure 4A). Much like cyto-
chalasin D-treated cells, ROCK-inhibited cells exhibited
decreased AP and increased lipid production as com-
pared to untreated controls (Figure 4B). While this shift
in lineages suggests that cell shape-mediated commit-
ment involves actomyosin contractility, it is possible that
drug treatment selects preadipogenic hMSCs by caus-
ing preosteogenic cells to die. To exclude this possibil-
ity, cells were first differentiated to adipocytes or osteo-
blasts, counted, then treated with cytochalasin D or
Y-27632 for 1 week. Cells were then recounted and as-
sayed to determine total cell number and viability. Treat-
ment with cytochalasin D or Y-27632 did not significantly
alter total number or viability of differentiated adipocytes
or osteoblasts (Figure 4C). These findings suggest a role
for the actomyosin cytoskeleton in hMSC commitment.
mixed media. Lipids stain red; alkaline phosphatase stains blue.
Scale bar  50 m.
(B and C) Percentage differentiation of hMSCs plated onto 1024,
2025, or 10,000 m2 islands after 1 week of culture in mixed media
without (B) or with (C) aphidicolin (2 g/ml) treatment.
Figure 3. Cell Shape Drives hMSC Commitment (D) Percentage of hMSCs remaining and viable after 1 week of
(A) Brightfield images of hMSCs plated onto small (1024 m2) or culture on 1024 or 10,000 m2 islands in mixed media and aphidi-
large (10,000 m2) fibronectin islands after 1 week in growth or colin treatment.
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Figure 4. hMSC Commitment Varies with Changes in Cytoskeletal Tension
(A and B) Brightfield image (A) and percentage differentiation (B) of hMSCs plated at low density (3000 cells/cm2) in mixed media after 1 week
without or with cytochalasin D (1 g/ml) or Y-27632 (10 M) treatment.
(C) Percentage of remaining and viable osteoblasts or adipocytes after 1 week of cytochalasin D (1 g/ml) or Y-27632 (10 M) treatment.
hMSC Shape Regulates RhoA Activity under osteogenic and adipogenic plating conditions. On
all days, RhoA activity was significantly higher in low-The dependence of the adipogenic-to-osteogenic shift
on cell spreading and ROCK-mediated cytoskeletal ten- versus high-density culture, regardless of culture media
(Figure 5D). Furthermore, osteogenic media further en-sion raised the possibility that contractile activity in-
creases with cell spreading. As the RhoA GTPase is a hanced RhoA activity, while adipogenic media sup-
pressed activation, though to a lesser extent. Thus,central regulator of contractility in many cells (Chrza-
nowska-Wodnicka and Burridge, 1996; Etienne-Manne- RhoA activity is greatest when cells are subconfluent in
osteogenic media, and lowest when cells are confluentville and Hall, 2002), we investigated whether RhoA ac-
tivity might transduce shape into a regulatory signal. in adipogenic media, spanning nearly a 7-fold difference
(Figure 5D). These findings suggest the possibility thatTo examine the levels of active RhoA under various
differentiation conditions, cells were plated at low (4000 RhoA may be involved in the final common pathway that
transduces cell density and soluble factors to regulatecells/cm2) or high (12,000 cells/cm2) densities and cul-
tured in osteogenic, adipogenic, or growth media (Figure hMSC commitment.
To examine whether the increased RhoA signaling at5A). Cells were harvested at days 2, 4, and 6. At the
time of harvest, cells plated at low densities were more subconfluence was specifically due to increased cell
spreading, we patterned hMSCs onto small or large is-well-spread (Figure 5B) and showed more pronounced
stress fiber formation than those plated at high den- lands and, on day 3, measured kinase activity of the
downstream Rho effector, ROCK. ROCK activity insities.
We first confirmed that serum stimulation of starved spread cells was significantly greater than that on round
cells; this activity was abrogated by treatment withhMSCs could activate RhoA, as has been shown for
many other cell types (Ren et al., 1999). Confluent Y-27632 (Figure 5E). Together, these findings demon-
strate that cell shape directly affects RhoA and ROCKhMSCs were serum starved, exposed to growth media,
and lysed. GTP-bound RhoA was isolated using the Rho activity.
binding domain of rhotekin as described by Ren et al.
(2000). Active and total RhoA were normalized to total RhoA Regulates the hMSC Commitment Switch
between Osteogenic or Adipogenic Fateprotein and blotted. Minutes after serum stimulation,
RhoA activity increased dramatically (Figure 5C). We As high levels of active RhoA correlated to osteogenic
conditions and low levels to adipogenic conditions, wethen examined the levels of active, GTP-bound RhoA
Cell Shape and Rho Regulate Stem Cell Fate
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Figure 5. hMSC Shape Regulates RhoA Activity
(A) Phase contrast images of hMSCs in growth medium (Growth), osteogenic (Osteo), or adipogenic differentiation media (Adipo), 2 days after
plating at 4000 or 12,000 cells/cm2. Scale bar  100 m.
(B) Morphometric analysis of area of cell spreading at days 2, 4, and 6 after plating at subconfluent (sc) or confluent (c) density.
(C) Western blot of total and active RhoA in serum-starved hMSCs, with () or without () serum stimulation.
(D) Western blots and quantification of active RhoA in hMSCs in growth and differentiation conditions, on days 2, 4, and 6 after plating at
subconfluent or confluent density.
(E) Western blots and quantification of MYPT1 phosphorylation by ROCK kinase immunoprecipitated from round or spread cells at day 3 of
culture, with or without the ROCK inhibitor Y-27632.
chose to investigate whether RhoA activity itself could lineage commitment, we examined whether cells at an
intermediate density (12,000 cells/cm2) exposed to adi-directly regulate hMSC lineage commitment. We used
adenoviral constructs of constitutively active (RhoA- pogenic conditions would differentiate when infected
with RhoA-V14, while osteogenesis was examined inV14) or dominant-negative (RhoA-N19) RhoA in tandem
with GFP to directly manipulate RhoA. hMSCs in nondif- RhoA-N19-infected hMSCs exposed to osteogenic me-
dia. Under adipogenic conditions, adipogenesis was in-ferentiating (growth) media conditions were infected
with RhoA-V14, RhoA-N19, or GFP control virus, then hibited by constitutively active RhoA. Remarkably,
these RhoA-V14-infected cells underwent significant os-fixed and stained for AP and lipids after 1 week. In
growth media, GFP-infected and uninfected cells did teogenesis. Similarly, dominant-negative RhoA abro-
gated osteogenic media-induced osteogenesis, and re-not exhibit osteogenesis or adipogenesis. Remarkably,
hMSCs infected with constitutively active RhoA-V14 be- directed cells to the adipogenic differentiation program
(Figure 6E). These studies suggest that RhoA can fullycame osteoblasts while those infected with dominant-
negative RhoA-N19 became adipocytes in the absence replace the signals mediated by the soluble differentia-
tion factors.of any inducing factors, as measured by AP or lipid
production as well as by RT-PCR for lineage markers
(Figures 6A–6C). The degree of commitment caused by
RhoA viral infection was comparable to that from stan- RhoA Regulates hMSC Commitment through
ROCK and Cytoskeletal Integritydard induction protocols (Figure 6D).
These results show that increasing or decreasing RhoA has many effectors; some act on cytoskeletal
structure and mechanics, while others do not. To exam-RhoA activity alone can switch hMSC commitment to
osteoblasts or adipocytes even in nondifferentiating me- ine whether RhoA-dependent commitment depends on
its cytoskeletal effects, RhoA-V14-infected hMSCs weredia. To investigate whether RhoA is necessary for hMSC
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treated with cytochalasin D (1g/ml) during the differen-
tiation process. The osteogenic shift induced by consti-
tutively active RhoA-V14 was abrogated by disrupting
actin (Figure 7A). Treatment with the ROCK inhibitor
Y-27632 (10M) or the myosin II inhibitor blebbistatin (50
M) also abrogated RhoA-V14-induced osteogenesis.
Interestingly, the redirecting of hMSC commitment by
manipulating RhoA signaling coincided with changes in
cell shape. That is, osteogenesis was associated with
spread cells, while adipogenesis led to cell rounding.
To directly examine whether RhoA fully mediates the
commitment signals affected by cell shape as well as
those from soluble factors, we examined whether acti-
vating RhoA rescues osteogenesis in round cells and
inactivating RhoA rescues adipogenesis in spread cells.
hMSCs were plated onto small and large fibronectin
islands and infected with RhoA-N19 or RhoA-V14. Round
cells infected with RhoA-N19 became adipocytes, while
spread cells infected with RhoA-V14 became osteo-
blasts (Figures 7B and 7C). The osteogenesis induced
in these cells was blocked by both Y-27632 and blebbis-
tatin (Figure 7D), indicating that the tension generating
system is required in this process. Surprisingly, constitu-
tively active RhoA-V14-infected cells failed to form
osteoblasts when round, and cell spreading blocked
dominant-negative RhoA-N19-induced adipogenesis
(Figures 7B and 7C). That is, cell shape and RhoA activity
are both necessary, but neither is sufficient, to drive the
switch in hMSC commitment.
While RhoA did not appear to be downstream of the
cell spreading requirement for osteogenesis, we ex-
plored whether ROCK fully mediated the osteogenic
commitment signal in both round and spread cells.
hMSCs were plated onto small and large fibronectin
islands and infected with adenovirus containing consti-
tutively active ROCK (ROCK3). Both round and spread
cells infected with ROCK3 became osteoblasts, and
the ROCK3-induced osteogenesis was inhibited by
blebbistatin (Figure 7E). Together, these findings sug-
gest that, while RhoA is downstream of soluble differen-
tiation signals, cell shape-mediated control of the adipo-
genic-to-osteogenic commitment switch is regulated via
ROCK-induced cytoskeletal tension.
Discussion
Like many stem cells, hMSCs differentiate into distinct
lineages depending on what local cues are present in
Figure 6. RhoA Regulates the hMSC Commitment Switch between their environment. Among the many cues required for
Osteogenic or Adipogenic Fate lineage-specific differentiation of hMSCs in vitro, initial
(A) Brightfield images of hMSCs after 1 week in differentiation media cell plating density appeared to be critically important
or virus infection. Adipo, adipogenic media; Osteo, osteogenic me-
but poorly understood (Pittenger et al., 1999). We nowdia; Growth, growth media; RN19, transduction of dominant-nega-
show that plating density alters cell shape, which pro-tive RhoA-N19; RV14, transduction of constitutively active RhoA-
vides the critical cue that regulates an adipogenic-V14. Lipids stain red; alkaline phosphatase stains blue. Scale bar 
50 m. osteogenic switch in hMSC lineage commitment. Fur-
(B and C) RT-PCR of adipogenic (B) and osteogenic (C) lineage thermore, we demonstrate that this commitment switch
markers of hMSCs harvested after 1 week in growth or differentiation is mediated through the RhoA-ROCK signaling pathway.
media, RhoA-N19 or RhoA-V14 virus infection.
Previous studies have suggested that changes in cell(D and E) Percentage adipogenic or osteogenic differentiation of
shape can regulate the degree of development of lin-hMSCs after 1 week in indicated media and viral transduction (me-
eage-specific markers, or differentiation, in precommit-dia/viral) condition.
ted preadipocytes or preosteoblasts (Spiegelman and
Ginty, 1983; Thomas et al., 2002). It has been shown that
RhoA also can promote differentiation in precommitted
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Figure 7. RhoA Effects on hMSC Commitment Require Cytoskeletal Integrity and ROCK Activity
(A) Brightfield images (top panels) of hMSCs infected with RhoA-N19 (RN19) or RhoA-V14 (RV14) in growth media conditions alone with or
without cytochalasin D (1 g/ml), Y-27632 (10 M), or blebbistatin (50 M) treatment for 1 week. Scale bar  50 m. Percentage (lower panel)
of hMSC adipogenic or osteogenic differentiation.
(B–D) Brightfield images and bar graphs of hMSC percent differentiation when plated onto 1024 or 10,000 m2 islands and transduced with
dominant-negative RhoA-N19 (B), constitutively active RhoA-V14 (C), or constitutively active RhoA-V14 with 10M Y-27632 or 50M blebbistatin
(D) treatment for 1 week. Scale bar  50 m.
(E) Brightfield images of hMSCs plated onto 1024 or 10,000 m2 islands and transduced with constitutively active ROCK (ROCK3), or
transduced with constitutively active ROCK and treated with 50 M blebbistatin for 1 week. Scale bar  50 m.
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smooth and skeletal muscle systems (Carnac et al.,
1998; Takano et al., 1998; Wei et al., 1998; Charrasse et
al., 2002). Sordella et al. (2003), having noted decreased
adipogenesis and increased myogenesis of embryonic
fibroblasts derived from mice deficient in an inactivator
of Rho, p190-B RhoGAP, suggested the possibility that
RhoA may affect lineage commitment as well as differen-
tiation, though provided no direct evidence for this link-
age. The demonstration that a clonal population of
hMSCs can become adipocytes or osteoblasts without
altering proliferation or apoptosis now provides direct
evidence that these shape- and RhoA-mediated signals
can act at an earlier stage in development, by regulating
the specification of the multipotent stem cell into distinct
cell lineages, rather than by differentially regulating dif-
ferentiation of precommitted precursors. Furthermore,
the finding that cell shape can alter stem cell commit-
ment prior to exposure to differentiation factors also
provides evidence to support that commitment and dif-
Figure 8. Model of a Mechanically Mediated Switch in hMSC Com-ferentiation are distinct targets of shape-mediated sig-
mitment to Adipogenic or Osteogenic Fate
naling, and adds to the growing body of evidence that
Cell shape acts as a mechanical cue, driving hMSC commitment
cells can employ the same signaling machinery for dif- between adipocyte and osteoblast when RhoA signaling and cy-
ferent purposes at different stages in their development. toskeletal tension are intact. Interference with cell shape, RhoA
Further examining the role of RhoA, we show that signaling, ROCK activity, or cytoskeletal tension alters hMSC com-
mitment. RhoA signaling appears necessary and sufficient to re-RhoA and Rho kinase (ROCK) activity is greater in
place soluble factor signaling while ROCK activity acts downstreamspread than unspread cells. Direct manipulation of RhoA
of cell shape.signaling replaced the cocktail of differentiation factors
present in the media. That is, inactivating RhoA caused
adipogenesis while activating RhoA promoted osteo-
Changes in cell spreading alter RhoA-mediated cy-genesis in media containing no differentiation factors.
toskeletal contractility, focal adhesion assembly, andRemarkably, even in osteogenic differentiation media,
downstream integrin signaling (Riveline et al., 2001; Ba-cells infected with adenovirus encoding dominant-nega-
laban et al., 2001; Tan et al., 2003; Chen et al., 2003).tive RhoA became adipocytes while constitutively active
In all, the interaction between cell shape, biochemicalRhoA induced osteogenesis in cells cultured in adipo-
signaling, and cytoskeletal tension demonstrated heregenic differentiation media. This central role of RhoA in
highlights the importance of cell structure and mechan-soluble signaling appears quite general, as RhoA has
ics in ultimately determining the mass and nature ofalso been shown to regulate IGF-1 mediated adipogen-
connective tissues that develop, and provides a molecu-esis and myogenesis (Sordella et al., 2003). The demon-
lar basis for the regulated feedback needed to achievestration that cell shape-mediated control of lineage
mechanical homeostasis of these tissues.specification also involves RhoA signaling indicates that
It has long been noted that the differentiation of stemRhoA may be a ubiquitous integrator of both structural
cells into multiple lineages is accompanied by dramaticand soluble cues in developmental processes.
changes in cell morphologies, probably in part due toExamining the downstream effects of RhoA, we found
changes in expression of integrins, cadherins, and cy-that the lineage specification signal occurs through the
toskeletal proteins. Here, the demonstration that me-RhoA effector, ROCK, and its effects on myosin-gener-
chanical cues—as conveyed by changes in cell shape—ated cytoskeletal tension. Interestingly, cells expressing
influence lineage commitment of stem cells not onlydominant-negative RhoA underwent adipogenesis only
if cells were round, not spread, while constitutively ac- illustrates the intertwined linkages between cell shape,
cytoskeletal mechanics, and developmental processes,tive RhoA induced osteogenesis only in spread cells. In
contrast, constitutive activation of ROCK induced os- but also highlights cell shape itself as a driving factor in
development. These linkages likely provide a feedbackteogenesis in both round and spread cells, hence by-
passing cell shape in regulating stem cell commitment. control mechanism by which complex morphogenetic
changes are tied to the programs of tissue specification.Thus while RhoA activity can supplant soluble factor
signaling, but not cell shape signaling, ROCK is fully While Wolff’s law of bone growth and remodeling articu-
lated a century ago that changes in force applied todownstream of both inductive signals (Figure 8).
The downstream regulation of RhoA signaling by cell bone result in changes in its structure, mass, and
strength (Wolff, 1892; Vuori, 1996), we have only begunshape could occur through multiple mechanisms. Rho
GTPase family members require localization to lipid rafts to reveal the intricate molecular connections between
tissue structure, function, and mass. Here, investiga-in the plasma membrane to be active (Adamson et al.,
1992; Hancock, 2003; Villalba et al., 2001); this localiza- tions into the mechanism of hMSC commitment reveal
the importance of these mechanochemical signals, andtion could be altered by cell shape. Ultimately, the mech-
anism by which RhoA-ROCK-tension signaling affects provide one example of how mechanical cues affect the
ever-evolving tissue microenvironment.stem cell fate may be transduced at focal adhesions.
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Experimental Procedures mM PMSF (all from Sigma). Lysates were centrifuged 3 min at 3000
rcf at 4	C. Supernatants were incubated with rhotekin binding
domain-beads (Upstate) for 45 min at 4	C, centrifuged 3 min at 3000Cell Culture and Reagents
Human mesenchymal stem cells were obtained from Cambrex Bio- rcf, washed three times using 50 mM Tris (pH 7.2), 0.5% NP-40,
500 mM NaCl, 1 mM MgCl2, 1 mM EGTA, 10 g/ml aprotinin/leupep-sciences and maintained in growth medium, or GM (DMEM, 10%
FBS, 0.3 mg/ml glutamine, 100 units/ml penicillin, and 100 g/ml tin, and 1 mM PMSF (all from Sigma), and then suspended in SDS-
PAGE buffer (1.5x/1.5% -mercaptoethanol). RhoA was detectedstreptomycin) per Pittenger et al. (2001). Only early passage hMSCs
were used for experimental studies. For adipogenic differentiation, by Western blotting using a monoclonal antibody to RhoA (Santa
Cruz Biotechnology). Blots were developed using ECL (AmershamhMSCs were exposed to a cycle of 3 days of adipogenic induction
medium (GM, 1M dexamethasone, 200M indomethacin, 10g/ml Pharmacia) and quantitated using a digital imager (VersaDoc,
Bio-Rad).insulin, and 0.5 mM methylisobutylxanthine; Cambrex Biosciences)
and then 1 day of adipogenic maintenance medium (GM, 10 g/
ml insulin) chronically. For osteogenic differentiation, hMSCs were ROCK Kinase Assay
cultured in osteogenic differentiation media (GM, 50 M ascorbic Immunoprecipitation was performed as described (Sahai and Mar-
acid-2-phosphate, 10 mM -glycerophosphate, and 100 nM dexa- shall, 2002). Cells were lysed in IP buffer (10 mM Tris-HCl at pH 7.5,
methasone). Mixed differentiation media (mixed media) contained 1% Triton X-100, 0.5% NP-40, 150 mM NaCl, 2 mM CaCl2, 0.1 mM
1:1 adipogenic induction:osteogenic differentiation media. To inhibit sodium orthovanadate, 10 g/ml aprotinin/leupeptin, and 1 mM
proliferation, cells were exposed to aphidicolin (2 g/ml; Sigma) PMSF [all from Sigma]), then centrifuged at 14,000 rcf for 4 min.
chronically or to mitomycin C (10 g/ml; Sigma) for 2 hr and washed Lysate was precleared by incubation with 25 l Protein G sepharose
three times with media. Blebbistatin (50 M; Tocris) was applied beads (Amersham Pharmacia) for 15 min and centrifugation for 2
with every media change. Cytochalasin D (1 g/ml; Sigma) and min at 14,000 rcf. Precleared lysate was then incubated with 5 l
Y-27632 (10 M; Tocris) were applied daily. of anti-ROCK-II antibody (Santa Cruz Biotechnology) for 30 min,
followed by incubation with 50 l of Protein G sepharose beads.
Beads were then washed four times with IP buffer and resuspendedCell Staining
in kinase assay buffer (50 mM HEPES [pH 7.4], 150 mM NaCl, 1 mMTo stain lipids, cells were fixed in 10% formalin, rinsed in water and
MgCl2, 1 mM MnCl2, 10 mM NaF, 1 mM sodium orthovanadate, 5%then 60% isopropanol, stained with 30 mg/ml Oil red O (Sigma) in
glycerol, 1% NP-40, 1 mM dithiothreitol, and 1 mM PMSF [all from60% isopropanol, and rinsed in water. Alkaline phosphatase was
Sigma]). ROCK kinase assay was performed per Ishizaki et al. (2000).stained using Sigma kit #85 per manufacturer instructions. In brief,
ATP (Sigma) and recombinant MYPT1 substrate (Upstate) were incu-samples were fixed in acetone/citrate, rinsed in water, and stained
bated with the bead-kinase assay buffer slurry in a reaction volumewith Fast Blue RR/naphthol. Cells were photographed and counted
of 50 l for 30 min at 37	C, then stopped by SDS-PAGE bufferusing a Nikon Eclipse TE200. For total cell counts, nuclei were
addition and boiled for 10 min at 95	C. Kinase activity was detectedstained with acridine orange. To assay cell viability, samples were
by Western blotting using anti-phospho-MYPT1 (Upstate).exposed to 4 M ethidium bromide and 2 M fluorescein-AM per
manufacturer instructions (Molecular Probes), and were counted
using a Nikon Eclipse TE200. Construction of Recombinant Adenoviruses
RhoA-V14, RhoA-N19, and GFP recombinant adenoviruses were
constructed using the AdEasy XL system (Stratagene) according toFACS Analysis
kit protocols. In brief, cDNA fragments encoding RhoA-V14 andCells were stained for alkaline phosphatase using the ELF-97 AP
RhoA-N19 were generated via site-directed mutagenesis from WT-detection kit per manufacturer instructions (Molecular Probes; Tel-
RhoA constructs (gifts from M. Philips, New York University andford et al., 2001). In brief, cells were suspended in 0.15 M sodium
P. Burbelo, Georgetown University), subcloned into pShuttle IRES-chloride, filtered through nylon mesh, fixed in 70% ethanol at 4	C
GFP1 vectors, then used to transform BJ5813 competent cells con-for 15 min, washed with 0.15 M sodium chloride and then detection
taining pADEASY1. Resulting plasmids were linearized and used tobuffer, and exposed to ELF-97 substrate. Cells were analyzed using
transfect HEK293 cells. High titer preparations of resulting adenovi-a He-Cad laser emitting simultaneously at 325 and 488 nm, and
rus were obtained by repeated freeze-thaw of cells, cleared by cen-fluorescence measured through a 530 nm bandpass filter.
trifugation, and purified via CsCl2 gradient centrifugation. Viral titer
was determined by serial dilution using hMSCs and observing GFPRT-PCR Analysis
fluorescence after 48 hr. In viral infection experiments, viral MOITotal RNA was isolated using RNA isolation and lipid tissue RNA
resulting in transduction efficiency of at least 80% was added toisolation kits (Qiagen); DNase was removed using RNase-free DNase
cells for 4 hr, at which time the media were replaced.kit (Qiagen) per manufacturer instructions. 1 g of total RNA was
used in cDNA synthesis with random hexamers as primers (Pro-
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